Crossroads Treatment Centers

What Crossroads Treatment Centers does

Crossroads Treatment Centers is a privately held outpatient provider of medication-assisted treatment (MAT) for opioid and alcohol use disorders, headquartered in Greenville, South Carolina. The company operates 120+ treatment centers across 10 U.S. states (Georgia, Kentucky, New Jersey, North Carolina, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, and one additional state) and reports 15,000+ active patients with a 4.8-star patient rating. Its service model is built on FDA-approved medications — methadone, buprenorphine/Suboxone, SUBLOCADE, BRIXADI, naltrexone/VIVITROL, acamprosate, and disulfiram — delivered alongside counseling (CBT, Motivational Interviewing), care coordination addressing social determinants of health, and certified peer support. Differentiated clinical assets include a proprietary Measurement-Based Care (MBC) outcomes framework, an Instant Intake service with under-10-minute average time to first appointment, and the Holly digital scheduling assistant.

The underlying platform is a multi-site outpatient clinical operation rather than a software product. Distribution is anchored by a 24/7/365 Patient Access Center, same-day and virtual appointments, and a dedicated Financial Services team that handles insurance verification across Medicaid, Medicare, TRICARE, VA CCN, and commercial payers, with self-pay and grant funding as supplemental streams. Ancillary revenue includes a guest-dosing service at $25 setup and $15 daily. The company maintains HIPAA, 42 CFR Part 2, and Legitscript compliance, has 20+ years of operating history, and reports 90%+ full-remission outcomes at 12 months and a 6-month retention rate 2.5x the national prescriber average — claims that, if verified, support a value-based care thesis. Ownership is described as founder/management-controlled with no disclosed PE/VC, parent company, or M&A history.

Name

Crossroads Treatment Centers

Legal name

Crossroads Treatment Centers

Website

https://ctc.care

Company type

Private

Operating status

Operating

Short description

Crossroads Treatment Centers is a privately held outpatient provider of medication-assisted treatment for opioid and alcohol use disorders, operating 120+ clinics across 10 U.S. states and serving 15,000+ patients with FDA-approved medications, counseling, and care coordination.

Ownership category

akta.pro rank

Headquarters

HQ city

Greenville

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Insurance Reimbursement: Revenue generated through reimbursement from Medicaid, Medicare, TRICARE, VA CCN, and commercial insurance providers for treatment services, medications, and counseling.
2. Self-Pay: Flexible out-of-pocket payment options for patients without insurance coverage or those preferring self-pay arrangements.
3. Grant Funding: Grant funding available at some locations to offset treatment costs for eligible patients who cannot afford care.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Crossroads Treatment Centers provides outpatient medication-assisted treatment (MAT) and recovery support services for individuals with opioid and alcohol use disorders. Its core offering combines FDA-approved medications (methadone, buprenorphine/Suboxone, SUBLOCADE, BRIXADI, naltrexone/VIVITROL, acamprosate, disulfiram) with counseling, care coordination, peer support, and clinical assessment, delivered across 120+ outpatient centers in 10 U.S. states with same-day and virtual intake.

Product overview

Crossroads Treatment Centers provides outpatient medication-based recovery support for people with alcohol or opioid use disorders through a coordinated service model. The core offering consists of Clinical Assessment, Treatment Medications (including methadone, buprenorphine/Suboxone, and long-acting injectables like SUBLOCADE and BRIXADI), Counseling, Care Coordination, Peer Support, Specialty Populations Services, and Financial Services. Additional features include Instant Intake for same-day appointments and the Holly digital scheduling assistant. The treatment approach combines FDA-approved medications with behavioral therapies, care coordination for social determinants of health, and peer support to provide comprehensive whole-person recovery care across 120+ locations in 10 states.

Differentiator

Problem solved

Functional benefit

Brands

• Holly: Digital appointment assistant for scheduling and rescheduling patient appointments.
• Instant Intake

Products and services

• Clinical Assessment Comprehensive initial and ongoing patient assessments conducted with providers and care coordinators to build customized, evidence-based treatment plans for individuals with opioid or alcohol use disorder.
• Treatment Medications FDA-approved medication-assisted treatment for opioid and alcohol use disorders including methadone, buprenorphine/Suboxone, SUBLOCADE, BRIXADI, naltrexone/VIVITROL, acamprosate, and disulfiram.
• Counseling Behavioral therapy and counseling integrated with medication-based recovery support, utilizing Cognitive Behavioral Therapy (CBT) and Motivational Interviewing (MI) techniques.
• Care Coordination Services connecting patients with community resources for housing, employment, food, transportation, healthcare access, and social support to address social determinants of health.
• Peer Support Recovery support connecting patients with certified peer support specialists who have personal experience with substance use disorders to provide mentorship and community.
• Specialty Populations Services Tailored treatment programs for specific groups including individuals with co-occurring disorders, LGBTQ+ community, patients with Hepatitis C, pregnant women, veterans, unhoused population, rural patients, and non-English speakers.
• Financial Services Payment and insurance support including Medicaid, Medicare, TRICARE, VA CCN, commercial insurance acceptance, self-pay options, and grant funding assistance.
• Guest Dosing Temporary dosing service allowing medication-assisted treatment patients to receive their medication at a different Crossroads location while traveling, with $25 setup and $15 daily fees.

Quantifiable outcome

• 90%+ patients achieve full remission at 12 months of treatment
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered minor.

• Pennsylvania Attorney General's OfficeminorStrategic or Co-development Partner · 5 March 2026Crossroads Treatment Centers hosted a roundtable with the Pennsylvania Attorney General's office at their North Broad Street Philadelphia location. Attendees included Attorney General Dave Sunday, demonstrating regulatory engagement and collaboration on opioid treatment issues.
• Virginia Association of Medication-Assisted Recovery Programs (VAMARP)minorStrategic or Co-development Partner · 29 October 2024Crossroads participated in the 2024 VAMARP Conference as a privileged attendee, engaging with industry peers and sharing insights on medication-assisted recovery programs.
• Healthcare Research CommunityminorStrategic or Co-development Partner · 16 October 2024Release of white paper on Measurement-Based Care (MBC) for Patients with Substance Use Disorder, positioning Crossroads as a thought leader in SUD treatment innovation.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Workit Health: Virtual SUD treatment provider offering buprenorphine and counseling via telemedicine. Comparable in MAT clinical offerings, increasingly competing for the same commercially insured and Medicaid SUD population.
• Ophelia Health: Telehealth MAT provider offering Suboxone treatment for OUD across multiple states. Competes for the same opioid use disorder patients through a virtual-first model.
• Bicycle Health: Telehealth-only buprenorphine provider for opioid use disorder, active in 30+ states. Comparable patient population but purely digital delivery model, increasingly competing for the same referral funnel.

Broad incumbents

• Acadia Healthcare: Public behavioral health operator with inpatient psychiatric and residential SUD facilities. Comparable end market (SUD treatment) and overlap on co-occurring disorder services, though focused on higher-acuity levels of care.
• Universal Health Services (UHS) Behavioral Health: Large public hospital and behavioral health operator with inpatient psychiatric and addiction medicine units. Comparable in SUD treatment market but serves higher-acuity, hospital-based levels of care.

Direct peers

• CleanSlate Centers: Outpatient addiction treatment chain specializing in MAT for opioid and alcohol use disorders. Directly comparable in evidence-based medication protocols and clinic-based delivery.
• BrightView Health: Outpatient SUD treatment provider offering MAT, counseling, and withdrawal management across multiple states. Closely comparable in ambulatory MAT model and patient population focus.
• BayMark Health Services: Largest U.S. outpatient MAT platform operating methadone clinics and buprenorphine programs across dozens of states. Directly comparable on service model, payer mix, and geographic rollout strategy.
• American Addiction Centers: Multi-state SUD treatment provider offering detox, residential, partial hospitalization, and outpatient services including MAT. Comparable across the outpatient MAT service line.
• Recovery Centers of America: Regional SUD treatment operator with inpatient, detox, and outpatient MAT services in the Mid-Atlantic and Northeast. Geographic overlap in PA/NJ and comparable outpatient offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtiktok.com/@crossroadscenters
• Facebookfacebook.com/CrossroadsCenters
• LinkedInlinkedin.com/company/crossroadscenters
• Instagraminstagram.com/crossroadscenters

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Crossroads Treatment Centers